FINWIRES · TerminalLIVE
FINWIRES

Piramal Pharma Swings to Consolidated Loss in Fiscal Q4

By

-- Piramal Pharma (NSE:PPLPHARMA, BOM:543635) swung to an attributable consolidated loss of 88.2 million Indian rupees in the fiscal fourth quarter ended March 31 from a profit of 1.54 billion rupees a year ago.

Loss per share came in at 0.07 rupees from earnings per share of 1.16 rupees a year earlier, the pharmaceutical company said in a filing to the Indian stock exchanges on Tuesday.

Revenue from operations in fiscal Q4 stood at 27.5 billion rupees, almost unchanged from a year ago.

Shares of the company fell nearly 1% in recent trade.

Related Articles

Australia

Wells Fargo Adjusts Price Target on Old Dominion Freight Line to $205 From $200

Old Dominion Freight Line (ODFL) has an average rating of hold and mean price target of $215.77, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $212.90, Change: $+3.55, Percent Change: +1.70%

$ODFL
Australia

B. Riley Adjusts FormFactor Price Target to $145 From $130, Maintains Neutral Rating

Price: $133.67, Change: $-1.86, Percent Change: -1.37%

$FORM
Australia

B. Riley Adjusts Warrior Met Coal Price Target to $117 From $120, Maintains Buy Rating

Price: $91.18, Change: $+1.15, Percent Change: +1.28%

$HCC